ERYTECH Pharma (ERYP) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsTrendsStock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period February 21, 2024 | finanznachrichten.dePhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketJanuary 19, 2024 | morningstar.comRoyalty Pharma PLC Class A RPRXJune 28, 2023 | finanznachrichten.deErytech Pharma S.A.: Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXMJune 28, 2023 | finance.yahoo.comPhaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXMJune 27, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital - June 26, 2023June 26, 2023 | finance.yahoo.comERYTECH and PHERECYDES announce merger and name change to PHAXIAM TherapeuticsJune 23, 2023 | finance.yahoo.comERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023June 20, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuitJune 15, 2023 | msn.comTech, Pharma Stocks Lead European Equities Higher in Thursday TradingJune 14, 2023 | finance.yahoo.comERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes PharmaJune 13, 2023 | benzinga.comErytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes CloserJune 13, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _May 31, 2023June 12, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH Responds to Akkadian's DisinformationJune 12, 2023 | finance.yahoo.comERYTECH Responds to Akkadian’s DisinformationJune 5, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with PherecydesJune 5, 2023 | finance.yahoo.comERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with PherecydesMay 24, 2023 | finance.yahoo.comERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023May 24, 2023 | msn.comPharma Stocks Lead European Equities Sharply Lower in Wednesday TradingMay 23, 2023 | businesswire.comPHERECYDES Announces the Availability of the Exemption Document Relating to the Proposed Combination With Erytech PharmaMay 23, 2023 | finance.yahoo.comERYTECH announces the availability of the exemption document relating to the proposed combination with PherecydesMay 23, 2023 | msn.comPharma Stocks Lead European Equities Modestly Lower in Tuesday TradingMay 19, 2023 | msn.comEuropean Equities Rise in Friday Trading, Poised to End Week HigherMay 17, 2023 | msn.comPharma Stocks Weigh Down European Equities in Wednesday TradingMay 16, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _May 15, 2023May 16, 2023 | msn.comPharma Stocks, Vodafone Lead European Equities Lower in Tuesday TradingMay 15, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH Provides Update on the Announced Combination with PHERECYDESMay 15, 2023 | finance.yahoo.comERYTECH Provides Update on the Announced Combination with PHERECYDESMay 12, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _April 30, 2023May 12, 2023 | msn.comEuropean Equities Traded as American Depositary Receipts Lower Again in Wednesday US TradingMay 9, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the First Quarter of 2023May 9, 2023 | theglobeandmail.comMicro Cap Bid Up Right Before Opening BellMay 9, 2023 | finance.yahoo.comERYTECH Provides Business and Financial Update for the First Quarter of 2023May 9, 2023 | finance.yahoo.comERYTECH Provides Business and Financial Update for the First Quarter of 2023April 17, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital MarketApril 17, 2023 | seekingalpha.comERYTECH receives approval to transfer its listing to Nasdaq Capital MarketApril 17, 2023 | finance.yahoo.comERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital MarketApril 14, 2023 | msn.comPharma Stocks Lead European Equities Lower Friday Trading, But Index Poised to End Week HigherApril 12, 2023 | msn.comPharma Stocks Lead European Equities Higher Wednesday TradingApril 12, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _March 31, 2023April 6, 2023 | msn.comPharma Stocks Lead European Equities Higher in Thursday TradingApril 6, 2023 | msn.comFinancial, Pharma Stocks Lift European Equities in Tuesday TradingApril 1, 2023 | morningstar.comPherecydes Pharma Announces Its 2022 Annual Financial Results and Specifies Its Development Plan For 2023March 22, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022March 22, 2023 | finance.yahoo.comERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022March 7, 2023 | msn.comFinancial, Pharma Stocks Drag European Equities Sharply Lower in Tuesday TradingMarch 6, 2023 | finance.yahoo.comMonthly information related to total number of voting rights and shares composing the share capital _February 28, 2023March 2, 2023 | msn.comFinancial Stocks Lead European Equities Lower in Thursday TradingFebruary 16, 2023 | finanznachrichten.deErytech Pharma S.A.: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage TherapiesFebruary 15, 2023 | finance.yahoo.comERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage TherapiesFebruary 14, 2023 | msn.comEuropean Equities Flat After Strong Start in Tuesday Trading Get ERYTECH Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ERYP and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY. Find out details on these three critical Nvidia partners immediately. ERYP Media Mentions By Week ERYP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERYP News Sentiment▼0.000.61▲Average Medical News Sentiment ERYP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERYP Articles This Week▼00▲ERYP Articles Average Week Get ERYTECH Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ERYP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CCCC News EDIT News TSHA News TRML News LXEO News TCRX News CABA News BDTX News SCLX News SLDB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ERYP) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ERYTECH Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share ERYTECH Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.